Top Markets
Coin of the day
Vicapsys Life Sciences, Inc. Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.

VICP
Rang in Aktien #25709
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive... Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12. VYBRIN is being investigated for multiple purposes: preventing the formation of post-surgical adhesions following abdominal operations, coating implantable medical devices and other implants to inhibit fibrosis, and promoting wound healing, with a particular emphasis on diabetic ulcers. The firm, originally incorporated in 1997, transitioned its name from Phage Therapeutics International, Inc. to Vicapsys Life Sciences, Inc. in September 2017. Its operations are headquartered in Suwanee, Georgia.
Aktienkurs
$1.45
Zuletzt synchronisiert: 2026-08-19
Marktkapitalisierung
$46.94M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-18.08%
Land
US
Handel Vicapsys Life Sciences, Inc. (VICP)

Kategorie

Aktien-Split-Historie für Vicapsys Life Sciences, Inc. (VICP)
Die Aktie Vicapsys Life Sciences, Inc. (Symbol: VICP) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 21, 2026 statt.
Eine VICP-Aktie, die vor dem Aug 21, 2026 gekauft wurde, entspricht heute 0 VICP-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US